aTyr Pharma Inc. (LIFE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    aTyr Pharma Inc.

    NASDAQ: LIFE · Real-Time Price · USD
    1.90
    0.05 (2.70%)
    At close: Jun 04, 2024, 10:00 PM

    aTyr Pharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -50.39M -45.34M -33.78M
    Depreciation & Amortization
    		 2.74M 1.7M 1.3M
    Stock-Based Compensation
    		 2.6M 2.15M 1.61M
    Other Working Capital
    		 2.7M 4.35M -4.24M
    Other Non-Cash Items
    		 -3.18M 441K 366K
    Deferred Income Tax
    		 n/a n/a 6K
    Change in Working Capital
    		 15.01M -833K -2.59M
    Operating Cash Flow
    		 -33.22M -41.89M -33.08M
    Capital Expenditures
    		 -4.21M -1.64M -192K
    Cash Acquisitions
    		 15K 179K 50K
    Purchase of Investments
    		 -106.98M -42.12M -126.51M
    Sales Maturities Of Investments
    		 91.05M 90.83M 35.08M
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -20.13M 47.24M -91.57M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 105K n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 66.23M 5.45M 110.03M
    Financial Cash Flow
    		 66.23M 5.45M 110.03M
    Net Cash Flow
    		 12.88M 10.81M -14.62M
    Free Cash Flow
    		 -37.44M -43.53M -33.27M

    Add to Watchlist